Selected research
Industry Growth & Trends
Global Over-The-Counter (OTC) Pet Medication Industry Growth and Trends Forecast to 2032
Market perspective
The global Over-The-Counter (OTC) Pet Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Over-The-Counter (OTC) Pet Medication include Merck Animal Health, Elanco, Zoetis, Virbac, Vet's Best, Vetoquinol, Sentry, Purdue Pharma L.P. and PetIQ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Over-The-Counter (OTC) Pet Medication market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Over-The-Counter (OTC) Pet Medication market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Over-The-Counter (OTC) Pet Medication market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Over-The-Counter (OTC) Pet Medication.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Over-The-Counter (OTC) Pet Medication market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Over-The-Counter (OTC) Pet Medication Market by Company
Merck Animal Health
Elanco
Zoetis
Virbac
Vet's Best
Vetoquinol
Sentry
Purdue Pharma L.P.
PetIQ
Perrigo
Nutramax Laboratories
Mobedco-Vet
Ceva Santé Animale
Boehringer Ingelheim
Antelope Pets
Over-The-Counter (OTC) Pet Medication Segment by Type
Dogs
Cats
Others
Over-The-Counter (OTC) Pet Medication Segment by Application
Online Sales
Offline Sales
Over-The-Counter (OTC) Pet Medication Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over-The-Counter (OTC) Pet Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Over-The-Counter (OTC) Pet Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over-The-Counter (OTC) Pet Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Over-The-Counter (OTC) Pet Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Over-The-Counter (OTC) Pet Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dogs
- Cats
- Others
Applications
- Online Sales
- Offline Sales
Companies covered
- Merck Animal Health
- Elanco
- Zoetis
- Virbac
- Vet's Best
- Vetoquinol
- Sentry
- Purdue Pharma L.P.
- PetIQ
- Perrigo
- Nutramax Laboratories
- Mobedco-Vet
- Ceva Santé Animale
- Boehringer Ingelheim
- Antelope Pets
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Over-The-Counter (OTC) Pet Medication Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Over-The-Counter (OTC) Pet Medication Sales Estimates and Forecasts (2021-2032)
- 1.3 Over-The-Counter (OTC) Pet Medication Market by Type
- 1.3.1 Dogs
- 1.3.2 Cats
- 1.3.3 Others
- 1.4 Global Over-The-Counter (OTC) Pet Medication Market Size by Type
- 1.4.1 Global Over-The-Counter (OTC) Pet Medication Market Size Overview by Type (2021-2032)
- 1.4.2 Global Over-The-Counter (OTC) Pet Medication Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Over-The-Counter (OTC) Pet Medication Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Over-The-Counter (OTC) Pet Medication Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Over-The-Counter (OTC) Pet Medication Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Over-The-Counter (OTC) Pet Medication Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Over-The-Counter (OTC) Pet Medication Industry Trends
- 2.2 Over-The-Counter (OTC) Pet Medication Industry Drivers
- 2.3 Over-The-Counter (OTC) Pet Medication Industry Opportunities and Challenges
- 2.4 Over-The-Counter (OTC) Pet Medication Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Over-The-Counter (OTC) Pet Medication Revenue (2021-2026)
- 3.2 Global Top Players by Over-The-Counter (OTC) Pet Medication Sales (2021-2026)
- 3.3 Global Top Players by Over-The-Counter (OTC) Pet Medication Price (2021-2026)
- 3.4 Global Over-The-Counter (OTC) Pet Medication Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Over-The-Counter (OTC) Pet Medication Major Company Production Sites & Headquarters
- 3.6 Global Over-The-Counter (OTC) Pet Medication Company, Product Type & Application
- 3.7 Global Over-The-Counter (OTC) Pet Medication Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Over-The-Counter (OTC) Pet Medication Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Over-The-Counter (OTC) Pet Medication Players Market Share by Revenue in 2025
- 3.8.3 2025 Over-The-Counter (OTC) Pet Medication Tier 1, Tier 2, and Tier 3
4 Over-The-Counter (OTC) Pet Medication Regional Status and Outlook
- 4.1 Global Over-The-Counter (OTC) Pet Medication Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Over-The-Counter (OTC) Pet Medication Historic Market Size by Region
- 4.2.1 Global Over-The-Counter (OTC) Pet Medication Sales in Volume by Region (2021-2026)
- 4.2.2 Global Over-The-Counter (OTC) Pet Medication Sales in Value by Region (2021-2026)
- 4.2.3 Global Over-The-Counter (OTC) Pet Medication Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Over-The-Counter (OTC) Pet Medication Forecasted Market Size by Region
- 4.3.1 Global Over-The-Counter (OTC) Pet Medication Sales in Volume by Region (2027-2032)
- 4.3.2 Global Over-The-Counter (OTC) Pet Medication Sales in Value by Region (2027-2032)
- 4.3.3 Global Over-The-Counter (OTC) Pet Medication Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Over-The-Counter (OTC) Pet Medication by Application
- 5.1 Over-The-Counter (OTC) Pet Medication Market by Application
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global Over-The-Counter (OTC) Pet Medication Market Size by Application
- 5.2.1 Global Over-The-Counter (OTC) Pet Medication Market Size Overview by Application (2021-2032)
- 5.2.2 Global Over-The-Counter (OTC) Pet Medication Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Over-The-Counter (OTC) Pet Medication Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Over-The-Counter (OTC) Pet Medication Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Over-The-Counter (OTC) Pet Medication Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Over-The-Counter (OTC) Pet Medication Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Merck Animal Health
- 6.1.1 Merck Animal Health Company Information
- 6.1.2 Merck Animal Health Business Overview
- 6.1.3 Merck Animal Health Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Merck Animal Health Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.1.5 Merck Animal Health Recent Developments
- 6.2 Elanco
- 6.2.1 Elanco Company Information
- 6.2.2 Elanco Business Overview
- 6.2.3 Elanco Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Elanco Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.2.5 Elanco Recent Developments
- 6.3 Zoetis
- 6.3.1 Zoetis Company Information
- 6.3.2 Zoetis Business Overview
- 6.3.3 Zoetis Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Zoetis Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.3.5 Zoetis Recent Developments
- 6.4 Virbac
- 6.4.1 Virbac Company Information
- 6.4.2 Virbac Business Overview
- 6.4.3 Virbac Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Virbac Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.4.5 Virbac Recent Developments
- 6.5 Vet's Best
- 6.5.1 Vet's Best Company Information
- 6.5.2 Vet's Best Business Overview
- 6.5.3 Vet's Best Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Vet's Best Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.5.5 Vet's Best Recent Developments
- 6.6 Vetoquinol
- 6.6.1 Vetoquinol Company Information
- 6.6.2 Vetoquinol Business Overview
- 6.6.3 Vetoquinol Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Vetoquinol Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.6.5 Vetoquinol Recent Developments
- 6.7 Sentry
- 6.7.1 Sentry Company Information
- 6.7.2 Sentry Business Overview
- 6.7.3 Sentry Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Sentry Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.7.5 Sentry Recent Developments
- 6.8 Purdue Pharma L.P.
- 6.8.1 Purdue Pharma L.P. Company Information
- 6.8.2 Purdue Pharma L.P. Business Overview
- 6.8.3 Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.8.5 Purdue Pharma L.P. Recent Developments
- 6.9 PetIQ
- 6.9.1 PetIQ Company Information
- 6.9.2 PetIQ Business Overview
- 6.9.3 PetIQ Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 PetIQ Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.9.5 PetIQ Recent Developments
- 6.10 Perrigo
- 6.10.1 Perrigo Company Information
- 6.10.2 Perrigo Business Overview
- 6.10.3 Perrigo Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Perrigo Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.10.5 Perrigo Recent Developments
- 6.11 Nutramax Laboratories
- 6.11.1 Nutramax Laboratories Company Information
- 6.11.2 Nutramax Laboratories Business Overview
- 6.11.3 Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.11.5 Nutramax Laboratories Recent Developments
- 6.12 Mobedco-Vet
- 6.12.1 Mobedco-Vet Company Information
- 6.12.2 Mobedco-Vet Business Overview
- 6.12.3 Mobedco-Vet Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Mobedco-Vet Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.12.5 Mobedco-Vet Recent Developments
- 6.13 Ceva Santé Animale
- 6.13.1 Ceva Santé Animale Company Information
- 6.13.2 Ceva Santé Animale Business Overview
- 6.13.3 Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.13.5 Ceva Santé Animale Recent Developments
- 6.14 Boehringer Ingelheim
- 6.14.1 Boehringer Ingelheim Company Information
- 6.14.2 Boehringer Ingelheim Business Overview
- 6.14.3 Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.14.5 Boehringer Ingelheim Recent Developments
- 6.15 Antelope Pets
- 6.15.1 Antelope Pets Company Information
- 6.15.2 Antelope Pets Business Overview
- 6.15.3 Antelope Pets Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Antelope Pets Over-The-Counter (OTC) Pet Medication Product Portfolio
- 6.15.5 Antelope Pets Recent Developments
7 North America by Country
- 7.1 North America Over-The-Counter (OTC) Pet Medication Sales by Country
- 7.1.1 North America Over-The-Counter (OTC) Pet Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026)
- 7.1.3 North America Over-The-Counter (OTC) Pet Medication Sales Forecast by Country (2027-2032)
- 7.2 North America Over-The-Counter (OTC) Pet Medication Market Size by Country
- 7.2.1 North America Over-The-Counter (OTC) Pet Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Over-The-Counter (OTC) Pet Medication Market Size by Country (2021-2026)
- 7.2.3 North America Over-The-Counter (OTC) Pet Medication Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Over-The-Counter (OTC) Pet Medication Sales by Country
- 8.1.1 Europe Over-The-Counter (OTC) Pet Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026)
- 8.1.3 Europe Over-The-Counter (OTC) Pet Medication Sales Forecast by Country (2027-2032)
- 8.2 Europe Over-The-Counter (OTC) Pet Medication Market Size by Country
- 8.2.1 Europe Over-The-Counter (OTC) Pet Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Over-The-Counter (OTC) Pet Medication Market Size by Country (2021-2026)
- 8.2.3 Europe Over-The-Counter (OTC) Pet Medication Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales by Country
- 9.1.1 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Over-The-Counter (OTC) Pet Medication Market Size by Country
- 9.2.1 Asia-Pacific Over-The-Counter (OTC) Pet Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Over-The-Counter (OTC) Pet Medication Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Over-The-Counter (OTC) Pet Medication Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Over-The-Counter (OTC) Pet Medication Sales by Country
- 10.1.1 South America Over-The-Counter (OTC) Pet Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026)
- 10.1.3 South America Over-The-Counter (OTC) Pet Medication Sales Forecast by Country (2027-2032)
- 10.2 South America Over-The-Counter (OTC) Pet Medication Market Size by Country
- 10.2.1 South America Over-The-Counter (OTC) Pet Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Over-The-Counter (OTC) Pet Medication Market Size by Country (2021-2026)
- 10.2.3 South America Over-The-Counter (OTC) Pet Medication Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales by Country
- 11.1.1 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Size by Country
- 11.2.1 Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Over-The-Counter (OTC) Pet Medication Value Chain Analysis
- 12.1.1 Over-The-Counter (OTC) Pet Medication Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Over-The-Counter (OTC) Pet Medication Production Mode & Process
- 12.2 Over-The-Counter (OTC) Pet Medication Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Over-The-Counter (OTC) Pet Medication Distributors
- 12.2.3 Over-The-Counter (OTC) Pet Medication Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst